Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
European Urology|April 2, 2013
European guidelines on upper tract urothelial carcinomas: 2013 updateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.European Urology|January 30, 2020
European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and ManagementEmma Jane Smith, Karin Plass, Julie Darraugh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.Antimicrobial Agents and Chemotherapy|November 25, 2004
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin BFritz Offner, Vladimir Krcmery, Marc Boogaerts, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral ResectionErik Veskimae, Selvarani Subbarayan, Riccardo Campi, et al.The Oncologist|January 25, 2015
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human useKyriaki Tzogani, Venke Skibeli, Ingunn Westgaard, et al.European Urology|May 7, 2013
Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinomaHendrika J Bekema, Steven MacLennan, Mari Imamura, et al.BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 5, 2025
Midlife plasma proteomic profiles indicate altered amyloid and tau processing in former elite rugby playersNeil Graham, Karl Zimmerman, Jessica Hain, et al.Pageof 9